1. Paracetamol (P; 50 and 300 mg/kg i.v.) was administered to the control and malaria-infected (MI) male Wistar rat in order to assess the effect of MI on the metabolism of paracetamol to its glucuronide (PG) and sulphate (PS) conjugates and their excretion in urine. 2. At a dose of 50 mg/kg, neither total clearance (Cl-T) (controls, 20.3+/-0.5; MI, 19.9+/-0.9, ml/min/kg; mean+/-SD, p > 0.05) nor the renal clearance of P (Cl-R) were affected by MI. Although the formation clearance of PG (Cli PG) was decreased by about 40% (controls, 6.6+/-1.1; MI, 3.9+/-0.9, ml/min/kg, p < 0.05), the formation clearance of PS (Cl-f PS) was increased by 30% in the MI rat (controls, 8.8+/-0.9; MI, 11.2+/-1.7, ml/min/kg, p < 0.05), and therefore Cl-m (controls, 19.7+/-0.5; MI, 19.2+/-0.8, ml/min/kg, P > 0.05) was unchanged by MI. 3. At a dose of 300 mg/kg, MI produced a significant decrease in the total clearance of P (Cl-T) (controls, 16.9+/-1.0; MI, 11.9+/-0.9, ml/min/kg, p < 0.05), metabolic clearance (Cl-m) (controls, 15.9+/-1.4; MI, 11.3+/-0.9, ml/min/kg, p < 0.05) and the formation clearance of PG (Cl-f PG) (controls, 7.9+/-1.3; MI, 4.7+/-1.5, ml/min/kg, p < 0.05) without affecting Cl-f PS and Cl-R of P. 4. These findings indicate that MI impairs the glucuronidation of paracetamol in rat in viva at both the low and high doses of P. Increased sulphate formation appeared to compensate for decreased glucuronidation at the lower dose. However, at the higher dose, this pathway is saturated and sulphation was unchanged.